C-Met Mutation-Related Tumors
1 clinical trials · Condition
◉ Watch C-Met Mutation-Related Tumors
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy Evaluation of GST-HG161 (NCT04228406) | Fujian Cosunter Pharmaceutical Co. Ltd | 2019-07-01 |
Track C-Met Mutation-Related Tumors automatically
Every clearance here is in the API, with alerts when new ones post.